FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Scopolamine Transdermal System
Status: Currently in Shortage
»Date first posted: 08/27/2018
»Therapeutic Categories: Endocrinology/Metabolism; Neurology

Expand all

GlaxoSmithKline (New 08/27/2018)

Company Contact Information:
908-293-5330

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Transderm (Scopolamine) 1.5 mg Patch 10 count (NDC 10019-553-03) Next delivery: 8/31/2018; Estimated recovery: December 2018 Demand increase for the drug
Transderm (Scopolamine) 1.5 mg Patch 24 count (NDC 10019-553-04) Next delivery: 10/2/2018; Estimated recovery: December 2018 Demand increase for the drug
Transderm (Scopolamine) 1.5 mg Patch 4 count (NDC 66758-208-54) Next delivery: 9/28/2018; Estimated recovery: December 2018 Demand increase for the drug

Perrigo Pharmaceuticals (New 08/27/2018)

Company Contact Information:
866-634-9120

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Scopolamine Transdermal System, 1mg/3days 4-Count Pack (NDC 45802-580-84) Unavailable
Scopolamine Transdermal System, 1mg/3days 10-Count Pack (NDC 45802-580-46) Unavailable
Scopolamine Transdermal System, 1mg/3days 24-Count Pack (NDC 45802-580-62) Unavailable

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English